Search

agbiopro
- Aug 19, 2020
- 0 min read

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership